Effects of lithium on oxidative stress parameters in healthy subjects

Molecular Medicine Reports

Volumn 5, Issue 3, 2012, Pages 680-682

  Khairova, Rushaniya ^a,c   Pawar, Rohit ^c   Salvadore, Giacomo ^a   Juruena, Mario F ^b   De Sousa, Rafael T ^b   Soeiro De Souza, Márcio G ^b   Salvador, Mirian ^d   Zarate, Carlos A ^a   Gattaz, Wagner F ^b   Machado Vieira, Rodrigo ^a,b  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c MAIMONIDES MEDICAL CENTER   (United States)

^d UNIVERSITY OF CAXIAS DO SUL   (Brazil)

Author keywords

Bipolar disorder; Healthy; Lithium; Oxidative stress; Superoxide dismutase

Indexed keywords

CATALASE; HYDROGEN PEROXIDE; LITHIUM; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BIPOLAR DISORDER; CELL LEVEL; CLINICAL TRIAL; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DOWN REGULATION; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG WITHDRAWAL; ENZYME BLOOD LEVEL; FATIGUE; FEMALE; HUMAN; MALE; NAUSEA; NEURONAL OXIDATIVE STRESS; NEUROPROTECTION; NORMAL HUMAN; OXIDATIVE STRESS; PATIENT COMPLIANCE; SOMNOLENCE; VOMITING;

ADULT; CATALASE; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; LITHIUM; MALE; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES; YOUNG ADULT;

EID: 84856243953     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2011.732     Document Type: Article

References (23)

1. Mahadik SP, Evans D and Lal H: Oxidative stress and role of antioxidant and omega-3 essential fatty acid supplementation in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 25: 463-469, 2001.
2. Machado-Vieira R, Andreazza AC, Viale CI, et al: Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects. Neurosci Lett 421: 33-36, 2007. (Pubitemid 46908861)
3. Zarate CA, Singh J Jr and Manji HK: Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder. Biol Psychiatry 59: 1006-1020, 2006.
4. Andreazza AC, Kauer-Sant'Anna M, Frey BN, et al: Effects of mood stabilizers on DNA damage in an animal model of mania. J Psychiatry Neurosci 33: 516-524, 2008.
5. Floyd RA: Antioxidants, oxidative stress, and degenerative neurological disorders. Proc Soc Exp Biol Med 222: 236-245, 1999.
6. Halliwell B: Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 18: 685-716, 2001.
7. Wang JF, Azzam JE and Young LT: Valproate inhibits oxidative damage to lipid and protein in primary cultured rat cerebrocortical cells. Neuroscience 116: 485-489, 2003. (Pubitemid 36139918)
8. Gsell W, Conrad R, Hickethier M, et al: Decreased catalase activity but unchanged superoxide dismutase activity in brains of patients with dementia of Alzheimer type. J Neurochem 64: 1216-1223, 1995.
9. Shao L, Young LT and Wang JF: Chronic treatment with mood stabilizers lithium and valproate prevents excitotoxicity by inhibiting oxidative stress in rat cerebral cortical cells. Biol Psychiatry 58: 879-884, 2005. (Pubitemid 41790716)
10. Andreazza AC, Cassini C, Rosa AR, et al: Serum S100B and antioxidant enzymes in bipolar patients. J Psychiatr Res 41: 523-529, 2007. (Pubitemid 46227446)
11. Machado-Vieira R, Manji HK and Zarate CA Jr: The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis. Bipolar Disord 11: 92-109, 2009.
12. Schafer M, Goodenough S, Moosmann B and Behl C: Inhibition of glycogen synthase kinase 3 beta is involved in the resistance to oxidative stress in neuronal HT22 cells. Brain Res 1005: 84-89, 2004. (Pubitemid 38388403)
13. Frey BN, Valvassori SS, Reus GZ, et al: Effects of lithium and valproate on amphetamine induced oxidative stress generation in an animal model of mania. J Psychiatry Neurosci 31: 326-332, 2006. (Pubitemid 44497429)
14. First MB and Gibbon RL: Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-patient Edition. (SCID-I/NP) New York: Biometrics Research, New York State Psychiatric Institute, 2002.
15. Mirsa HP and Fridovich I: The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 217: 3170-3175, 1972.
16. Aebi H: Catalase in vitro. Methods Enzymol 105: 121-126, 1984.
17. Wills ED: Mechanisms of lipid peroxide formation in animal tissues. Biochem J 19: 667-676, 1966.
18. Ranjekar PK, Mahadik SP, Hegde MV, et al: Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients. Psychiatry Res 121: 109-122, 2003. (Pubitemid 37500981)
19. Liochev SI and Fridovich I: The relative importance of HO*and. Free Radic Biol Med 26: 777-778, 1999.
20. Frey BN, Martins MR, Petronilho FC, Dal-Pizzol F, Quevedo J and Kapczinski F: Increased oxidative stress after repeated amphetamine exposure: possible relevance as a model of mania. Bipolar Disord 8: 275-280, 2006.
21. Tandon A, Dhawan DK and Nagpaul JP: Effect of lithium on hepatic lipid peroxidation and antioxidative enzymes under different dietary protein regimens. J Appl Toxicol 18: 187-190, 1998. (Pubitemid 28313937)
22. Machado-Vieira R, Soares JC, Lara DR, et al: A double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of the purinergic agents allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania. J Clin Psychiatry 69: 1237-1245, 2008.
23. Bowden CL, Brugger AM, Swann AC, et al: Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. JAMA 271: 918-924, 1994. (Pubitemid 24083217)